Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation
- 1 February 2006
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 19 (2) , 128-139
Abstract
For kidney transplant recipients with donor-specific antibody (DSA) to HLA- (+XM) or ABO-antigens (ABOI), there is a need to improve detection and treatment of antibody-mediated rejection (AMR). The methods included a retrospective review of consecutive patients that received plasmapheresis and immune globulin (PPIVIg) to abrogate +XM or ABOI. Twelve patients were transplanted after PPIVIg (+XM = 9, ABOI = 2, +XM/ABOI = 1). No hyperacute rejections occurred. Rejection occurred in seven patients [four AMR, three acute cellular rejection (ACR)]. In four +XM patients, DSA was detected during graft dysfunction despite lack of histologic and C4d features of AMR. In one patient, DSA preceded the histologic and immunofluorescent features of AMR. In another patient with borderline changes and DSA, graft function improved after PPIVIg, despite lack of histologic or immunofluorescent evidence of AMR. One patient with Banff IIA ACR and DSA treated with antithymocyte antibody but not PPIVIg had recurrent rejections and poor graft function. In +XM and ABOI recipients with graft dysfunction: (i) DSA may represent AMR in the absence of C4d or histologic features of AMR; (ii) DSA can precede C4d or light microscopic features of AMR; (iii) A poor outcome may result if DSA or continued allograft dysfunction is present and not treated despite a negative biopsy.Keywords
This publication has 25 references indexed in Scilit:
- National Conference to Assess Antibody-Mediated Rejection in Solid Organ TransplantationAmerican Journal of Transplantation, 2004
- Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patientsTransplantation, 2003
- Study 3: outcome of ABO-incompatible kidney transplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroidsTransplantation Reviews, 2003
- Study 1: characterization of acute rejection episodes after pre-emptive plasmapheresis and cytomegalovirus hyperimmune globulin to abrogate a positive crossmatch and allow live donor renal transplantationTransplantation Reviews, 2003
- Utility of Intravenous Immune Globulin in Kidney Transplantation: Efficacy, Safety, and Cost ImplicationsAmerican Journal of Transplantation, 2003
- Desensitization and Subsequent Kidney Transplantation of Patients Using Intravenous Immunoglobulins (IVIg)American Journal of Transplantation, 2002
- C4d staining of perioperative renal transplant biopsies1Transplantation, 2002
- ANTI-AB TITER CHANGES IN PATIENTS WITH ABO INCOMPATIBILITY AFTER LIVING RELATED KIDNEY TRANSPLANTATIONSTransplantation, 2000
- Rejection associated with early appearance of donor-reactive antibodies after kidney transplantation treated with plasmapheresis and administration of 15-deoxyspergualinTransplant International, 1992
- THE SIGNIFICANCE OF THE ANTI–CLASS I RESPONSETransplantation, 1992